Badger Meter, Inc. (BMI) Price Target Analysis
Updated Jun 18, 2026
Analyst Rating: Hold
Based on 18 analysts17.0% Below Target
BMI trades 17.0% below Wall Street's consensus target of $158.50.
Current Price$135.50
Average Target$158.50
Target
Current
Low$110.00
Median$156.00
High$220.00
Analyst Target Range
Forward P/E30.1x
(Growth Premium)
PEG Ratio1.30
(Fair)
Implied Growth-6.2%
(Declining)
Analyst Spread69.4%
(Wide Disagreement)
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Consensus Scenario Assumptions
The base valuation assumes BMI achieves its forward estimates and maintains a stable P/E multiple of 30.1x. This scenario reflects the blended consensus of 18 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
BMI Price Target Analysis
Updated June 22, 2026As of June 22, 2026, Badger Meter, Inc. (BMI) has a Wall Street consensus price target of $158.50, based on estimates from 18 covering analysts. With the stock currently trading at $135.50, this represents a potential upside of +17.0%. The company has a market capitalization of $3.99B.
Analyst price targets range from a low of $110.00 to a high of $220.00, representing a 69% spread in expectations. The median target of $156.00 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Hold, with 5 analysts rating the stock as a Buy or Strong Buy,10 rating it Hold, and 3 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, BMI trades at a trailing P/E of 28.3x and forward P/E of 30.1x. The forward PEG ratio of 1.30 indicates reasonable valuation for growth. Analysts expect EPS to grow -6.2% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $135.41, with bear and bull scenarios of $85.31 and $178.41 respectively. Model confidence stands at 52/100, reflecting moderate uncertainty in projections.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Technology stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside
+23.9%
Industry Consensus
Avg Forward P/E
19.9x
(Fair)
Peers with Coverage
10 / 10
Active Analyst Tracking
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 ITRIItron, Inc. | $3.6B | $80.81 | $136.80 | +69.3% | Hold | 13.5x | 37 |
 FELEFranklin Electric Co., Inc. | $4.6B | $104.20 | $100.00 | -4.0% | Hold | 22.7x | 11 |
 ERIIEnergy Recovery, Inc. | $486M | $9.42 | $12.50 | +32.7% | Buy | — | 16 |
 MWAMueller Water Products, Inc. | $4.1B | $26.13 | $32.25 | +23.4% | Hold | 17.7x | 21 |
 XYLXylem Inc. | $26.5B | $111.42 | $151.57 | +36.0% | Hold | 20.1x | 40 |
 AWKAmerican Water Works Company, Inc. | $24.4B | $125.07 | $131.67 | +5.3% | Buy | 20.6x | 30 |
 AMEAMETEK, Inc. | $54.4B | $237.42 | $250.00 | +5.3% | Buy | 29.2x | 29 |
 ROPRoper Technologies, Inc. | $34.0B | $330.25 | $457.64 | +38.6% | Buy | 15.1x | 23 |
 DHRDanaher Corporation | $125.4B | $177.17 | $230.89 | +30.3% | Buy | 21.0x | 43 |
 SWKStanley Black & Decker, Inc. | $13.5B | $86.75 | $88.67 | +2.2% | Hold | 19.1x | 37 |
BMI — Frequently Asked Questions
Quick answers to the most common questions about buying BMI stock.
What is the BMI stock price target for 2026?
Badger Meter, Inc. (BMI) has a consensus 12-month price target of $158.5, implying 17.0% upside from $135.5. The 18 analysts covering BMI see moderate appreciation potential.
Is BMI a buy, sell, or hold?
BMI has a consensus rating of "Hold" based on 18 Wall Street analysts. The rating breakdown is mixed, with 10 Hold ratings making up the largest segment. The consensus 12-month price target of $158.5 implies 17.0% upside from current levels.
Is BMI stock overvalued or undervalued?
BMI trades at a forward P/E of 30.1245x, representing a moderate valuation. With analysts targeting $158.5 (17.0% implied move), the stock appears reasonably valued with upside.
How high can BMI stock go?
The most bullish Wall Street analyst has a price target of $220 for BMI, while the most conservative target is $110. The consensus of $158.5 represents the median expectation. Our quantitative valuation model projects a bull case target of $178 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover BMI stock?
BMI is well covered by analysts, with 18 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 5 have Buy ratings, 10 recommend Hold, and 3 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the BMI stock forecast?
The 12-month BMI stock forecast based on 18 Wall Street analysts shows a consensus price target of $158.5, with estimates ranging from $110 (bear case) to $220 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $135, with bear/bull scenarios of $85/$178.
What is BMI's fair value based on fundamentals?
Our quantitative valuation model calculates BMI's fair value at $135 (base case), with a bear case of $85 and bull case of $178. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 52/100.
What is BMI's forward P/E ratio?
BMI trades at a forward P/E ratio of 30.1x based on next-twelve-months earnings estimates compared to a trailing P/E of 28.3x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy BMI stock?
Wall Street analysts are optimistic on BMI, with a "Hold" consensus rating and $158.5 price target (17.0% upside). 5 of 18 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do BMI price targets vary so much?
BMI analyst price targets range from $110 to $220, a 69% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $158.5 consensus represents the middle ground. Our model's $85-$178 range provides an independent fundamental perspective.
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare